TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis, Journal of Biological Chemistry, vol.272, issue.51, pp.32401-32410, 1997. ,
DOI : 10.1074/jbc.272.51.32401
TWEAK/Fn14 Interactions Are Instrumental in the Pathogenesis of Nephritis in the Chronic Graft-versus-Host Model of Systemic Lupus erythematosus, The Journal of Immunology, vol.179, issue.11, pp.7949-7958, 2007. ,
DOI : 10.4049/jimmunol.179.11.7949
TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade, Annals of the Rheumatic Diseases, vol.69, issue.01, pp.301-304, 2010. ,
DOI : 10.1136/ard.2008.090548
The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases, Journal of Leukocyte Biology, vol.92, issue.2, pp.265-279, 2012. ,
DOI : 10.1189/jlb.0112042
Role of TWEAK in lupus nephritis: A bench-to-bedside review, Journal of Autoimmunity, vol.39, issue.3, pp.130-142, 2012. ,
DOI : 10.1016/j.jaut.2012.05.003
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses, Immunological Reviews, vol.12, issue.Suppl., pp.99-114, 2011. ,
DOI : 10.1111/j.1600-065X.2011.01054.x
TWEAK Induces Angiogenesis and Proliferation of Endothelial Cells, Journal of Biological Chemistry, vol.274, issue.13, pp.8455-8459, 1999. ,
DOI : 10.1074/jbc.274.13.8455
Dual role for TWEAK in angiogenic regulation, J Cell Sci, vol.115, pp.267-274, 2002. ,
TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity, Journal of Neuroimmunology, vol.133, issue.1-2, pp.116-123, 2002. ,
DOI : 10.1016/S0165-5728(02)00368-5
Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis, Clinical Immunology, vol.117, issue.1, pp.15-23, 2005. ,
DOI : 10.1016/j.clim.2005.06.005
TWEAK stimulation of astrocytes and the proinflammatory consequences, Glia, vol.161, issue.1, pp.102-107, 2000. ,
DOI : 10.1002/1098-1136(200010)32:1<102::AID-GLIA100>3.0.CO;2-U
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Increases the Permeability of the Neurovascular Unit through Nuclear Factor-??B Pathway Activation, Journal of Neuroscience, vol.25, issue.44, pp.10094-10100, 2005. ,
DOI : 10.1523/JNEUROSCI.3382-05.2005
The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent, The Journal of Cell Biology, vol.125, issue.5, pp.1165-1178, 1994. ,
DOI : 10.1083/jcb.125.5.1165
Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury, Neurology, vol.46, issue.6, pp.1626-1632, 1996. ,
DOI : 10.1212/WNL.46.6.1626
Role for Matrix Metalloproteinase 9 After Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition With BB-94, Journal of Cerebral Blood Flow & Metabolism, vol.18, pp.1681-1689, 2000. ,
DOI : 10.1097/00004647-200012000-00007
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood?brain barrier and white matter components after cerebral ischemia, J Neurosci, vol.21, pp.7724-7732, 2001. ,
A Soluble Fn14-Fc Decoy Receptor Reduces Infarct Volume in a Murine Model of Cerebral Ischemia, The American Journal of Pathology, vol.166, issue.2, pp.511-520, 2005. ,
DOI : 10.1016/S0002-9440(10)62273-0
The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system, Journal of Neuroinflammation, vol.105, issue.1, p.45, 2012. ,
DOI : 10.1186/1742-2094-9-45
Expression of TWEAK and Its Receptor Fn14 in the Multiple Sclerosis Brain: Implications for Inflammatory Tissue Injury, Journal of Neuropathology & Experimental Neurology, vol.67, issue.12, pp.1137-1148, 2008. ,
DOI : 10.1097/NEN.0b013e31818dab90
TWEAK is expressed at the cell surface of monocytes during multiple sclerosis, Journal of Leukocyte Biology, vol.85, issue.1, pp.132-135, 2009. ,
DOI : 10.1189/jlb.0608347
Blood-brain barrier-specific properties of a human adult brain endothelial cell line, The FASEB Journal, vol.19, pp.1872-1874, 2005. ,
DOI : 10.1096/fj.04-3458fje
Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia, European Journal of Neuroscience, vol.10, issue.1, pp.19-32, 2002. ,
DOI : 10.1046/j.1460-9568.1999.00434.x
Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells, Molecular and Cellular Neuroscience, vol.39, issue.4, pp.549-568, 2008. ,
DOI : 10.1016/j.mcn.2008.08.004
URL : https://hal.archives-ouvertes.fr/hal-00417416
Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, vol.4, issue.11, pp.1716-1723, 2009. ,
DOI : 10.2215/CJN.02760409
Tumor Necrosis Factor-related Weak Inducer of Apoptosis Augments Matrix Metalloproteinase 9 (MMP-9) Production in Skeletal Muscle through the Activation of Nuclear Factor-??B-inducing Kinase and p38 Mitogen-activated Protein Kinase: A POTENTIAL ROLE OF MMP-9 IN MYOPATHY, Journal of Biological Chemistry, vol.284, issue.7, pp.4439-4450, 2009. ,
DOI : 10.1074/jbc.M805546200
TNF-Like Weak Inducer of Apoptosis (TWEAK) Activates Proinflammatory Signaling Pathways and Gene Expression through the Activation of TGF-??-Activated Kinase 1, The Journal of Immunology, vol.182, issue.4, pp.2439-2448, 2009. ,
DOI : 10.4049/jimmunol.0803357
Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes, Glia, vol.924, issue.1/2, pp.344-366, 2010. ,
DOI : 10.1002/glia.20927
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood?brain barrier and white matter components after cerebral ischemia, J Neurosci, vol.21, pp.7724-7732, 2001. ,
The TWEAK???Fn14 cytokine???receptor axis: discovery, biology and therapeutic targeting, Nature Reviews Drug Discovery, vol.109, issue.5, p.411, 2008. ,
DOI : 10.1002/jnr.21443
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Neurodegeneration, Journal of Neuroscience, vol.24, issue.38, pp.8237-8244, 2004. ,
DOI : 10.1523/JNEUROSCI.1089-04.2004
Neuronal ischemic injury: Light microscopy, ultrastructure and biochemistry, Acta Neuropathologica, vol.13, issue.Suppl. I, pp.85-95, 1978. ,
DOI : 10.1007/BF00685002
PATTERNS OF BLOOD-BRAIN BARRIER BREAKDOWN IN INFLAMMATORY DEMYELINATION, Brain, vol.114, issue.2, pp.801-810, 1991. ,
DOI : 10.1093/brain/114.2.801
Impaired transport of leptin across the blood-brain barrier in obesity???, Peptides, vol.20, issue.11, pp.1341-1345, 1999. ,
DOI : 10.1016/S0196-9781(99)00139-4
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor???related protein, Journal of Clinical Investigation, vol.112, issue.10, pp.1533-1540, 2003. ,
DOI : 10.1172/JCI200319212
The blood???brain barrier: an overview, Neurobiology of Disease, vol.16, issue.1, pp.1-13, 2004. ,
DOI : 10.1016/j.nbd.2003.12.016
Immune cell entry into the central nervous system: Involvement of adhesion molecules and chemokines, Journal of the Neurological Sciences, vol.274, issue.1-2, pp.23-26, 2008. ,
DOI : 10.1016/j.jns.2008.05.019
Potential role of MCP-1 in endothelial cell tight junction `opening': signaling via Rho and Rho kinase, Journal of Cell Science, vol.116, issue.22, pp.4615-4628, 2003. ,
DOI : 10.1242/jcs.00755
Monocyte Chemoattractant Protein-1 Regulation of Blood???Brain Barrier Permeability, Journal of Cerebral Blood Flow & Metabolism, vol.277, issue.8, pp.593-606, 2005. ,
DOI : 10.4049/jimmunol.172.7.4410
Effects of the Chemokine CCL2 on Blood???Brain Barrier Permeability during Ischemia???Reperfusion Injury, Journal of Cerebral Blood Flow & Metabolism, vol.176, issue.6, pp.797-810, 2006. ,
DOI : 10.1111/j.1750-3639.2002.tb00430.x
Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption, Journal of Cell Science, vol.124, issue.9, pp.1486-1495, 2011. ,
DOI : 10.1242/jcs.082834
Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies, Arthritis Research, vol.4, issue.2, pp.126-133, 2002. ,
DOI : 10.1186/ar388
Novel function of TWEAK in inducing intervertebral disc degeneration, Journal of Orthopaedic Research, vol.30, issue.11, pp.1438-1446, 2007. ,
DOI : 10.1002/jor.20445
TWEAK Can Induce Pro-Inflammatory Cytokines and Matrix Metalloproteinase-9 in Macrophages, Circulation Journal, vol.68, issue.4, pp.396-399, 2004. ,
DOI : 10.1253/circj.68.396
Matrix Metalloproteinase Inhibition Prevents Oxidative Stress-Associated Blood???Brain Barrier Disruption After Transient Focal Cerebral Ischemia, Journal of Cerebral Blood Flow & Metabolism, vol.85, pp.1393-1400, 2001. ,
DOI : 10.1097/00004647-200112000-00003
A New Role for TIMP-1 in Modulating Neurite Outgrowth and Morphology of Cortical Neurons, PLoS ONE, vol.4, issue.12, p.8289, 2009. ,
DOI : 10.1371/journal.pone.0008289.s004
Localization of matrix metalloproteinase 9??to the cell surface provides a mechanism for CD44-mediated tumor invasion, Genes & Development, vol.13, issue.1, pp.35-48, 1999. ,
DOI : 10.1101/gad.13.1.35
The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9, The EMBO Journal, vol.14, issue.19, pp.3758-3768, 2004. ,
DOI : 10.1002/cyto.a.10059
TWEAK Is an Endothelial Cell Growth and Chemotactic Factor That Also Potentiates FGF-2 and VEGF-A Mitogenic Activity, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.4, pp.594-600, 2003. ,
DOI : 10.1161/01.ATV.0000062883.93715.37
TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-??B through TNF receptor-associated factors, Biochemical and Biophysical Research Communications, vol.305, issue.4, pp.789-796, 2003. ,
DOI : 10.1016/S0006-291X(03)00852-0
TWEAK can induce cell death via endogenous TNF and TNF receptor 1, European Journal of Immunology, vol.15, issue.6, pp.1785-1792, 1999. ,
DOI : 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U
Neuronal prostaglandin endoperoxide synthase 2 responses to oxygen and glucose deprivation are mediated by mitogen-activated protein kinase ERK1/2, Brain Research, vol.1060, issue.1-2, pp.100-107, 2005. ,
DOI : 10.1016/j.brainres.2005.08.033
Prolonged Activation of NF-??B Following Traumatic Brain Injury in Rats, Journal of Neurotrauma, vol.16, issue.11, pp.1023-1034, 1999. ,
DOI : 10.1089/neu.1999.16.1023
Lack of the p50 subunit of nuclear factor-kappa B increases the vulnerability of hippocampal neurons to excitotoxic injury, J Neurosci, vol.19, pp.8856-8865, 1999. ,
Matrix metalloproteinases inhibition provides neuroprotection against hypoxiaischemia in the developing brain, pp.726-736, 2009. ,
Inducible Expression of Tissue Inhibitor of Metalloproteinases???Resistant Matrix Metalloproteinase-9 on the Cell Surface of Neutrophils, American Journal of Respiratory Cell and Molecular Biology, vol.29, issue.3, pp.283-294, 2003. ,
DOI : 10.1165/rcmb.2003-0034OC
Protein Kinase C??-RhoA Cross-talk in CCL2-induced Alterations in Brain Endothelial Permeability, Journal of Biological Chemistry, vol.281, issue.13, pp.8379-8388, 2006. ,
DOI : 10.1074/jbc.M513122200
Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium, Brain, vol.123, issue.4, pp.698-709, 2000. ,
DOI : 10.1093/brain/123.4.698
Suppression of MMP-9 Expression in Brain Microvascular Endothelial Cells (BMVEC) Using a Gold Nanorod (GNR)-siRNA Nanoplex, Immunological Investigations, vol.5, issue.17, pp.337-355, 2012. ,
DOI : 10.1021/nl063031m
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier, Journal of Neuroinflammation, vol.41, issue.Pt 2, p.9, 2013. ,
DOI : 10.1186/1742-2094-10-9
URL : https://hal.archives-ouvertes.fr/inserm-00787290